To be honest I see your point, but at the end of the day this is a company that is close to entering a phase 3 end stage trial in Europe with virtually no legitimate competition at sub 200M MC. (I’m not considering Exondys-51 as actual competition). I think that post december we should see some organic upwards growth once all of our traders have churned and instos have consolidated their positions.
$15m cap raise Fresh Equities at 24c, page-322
-
- There are more pages in this discussion • 534 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.71M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7158 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 29288 | 1 |
View Market Depth
| Last trade - 11.45am 26/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable